resveratrol has been researched along with zithromax in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Mahady, GB; Pendland, SL; Schriever, C | 1 |
| Adamcova, M; Carazo, A; Cermanova, J; Dolezelova, E; Hroch, M; Hyrsova, L; Micuda, S; Mokry, J; Mrkvicova, A; Pavek, P; Prasnicka, A | 1 |
3 other study(ies) available for resveratrol and zithromax
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Red wine, resveratrol, Chlamydia pneumoniae and the French connection.
Topics: Azithromycin; Chlamydophila Infections; Chlamydophila pneumoniae; Coronary Artery Disease; Female; France; Humans; Male; Microbial Sensitivity Tests; Platelet Aggregation Inhibitors; Primary Prevention; Prognosis; Resveratrol; Risk Assessment; Stilbenes; United States; Wine | 2003 |
Resveratrol modifies biliary secretion of cholephilic compounds in sham-operated and cholestatic rats.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; ATP-Binding Cassette Transporters; Azithromycin; Bile Acids and Salts; Cholestasis; Disease Models, Animal; Glutathione; Hepatocytes; Humans; Liver; Male; Pregnane X Receptor; Rats; Rats, Wistar; Receptors, Steroid; Resveratrol; Stilbenes | 2017 |